{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:52:14Z","timestamp":1781927534244,"version":"3.54.5"},"reference-count":50,"publisher":"Tohoku University Medical Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.1620\/tjem.2025.j085","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T18:09:35Z","timestamp":1751479775000},"page":"155-165","source":"Crossref","is-referenced-by-count":0,"title":["The Association of High Mobility Group Box-1 with Sepsis Susceptibility and Mortality Risk: A Meta-Analysis"],"prefix":"10.1620","volume":"269","author":[{"given":"Shuqi","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Zibo Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfeng","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Zibo Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingqian","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Zibo Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Zibo Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"Ackerman, M.H., Ahrens, T., Kelly, J.&amp;Pontillo, A. (2021)  Sepsis. <i>Crit. Care Nurs. Clin. North Am.<\/i>, 33, 407-418. https:\/\/doi.org\/10.1016\/j.cnc.2021.08.003","DOI":"10.1016\/j.cnc.2021.08.003"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Beltr\u00e1n-Garc\u00eda, J., Manclus, J.J., Garcia-Lopez, E.M., Carbonell, N., Ferreres, J., Rodriguez-Gimillo, M., Garces, C., Pallardo, F.V., Garcia-Gimenez, J.L., Montoya, A.&amp;Roma-Mateo, C. (2021)  Comparative Analysis of Chromatin-Delivered Biomarkers in the Monitoring of Sepsis and Septic Shock: A Pilot Study. <i>Int. J. Mol. Sci.<\/i>, 22, 9935. https:\/\/doi.org\/10.3390\/ijms22189935","DOI":"10.3390\/ijms22189935"},{"key":"3","doi-asserted-by":"publisher","unstructured":"Cai, J.&amp;Lin, Z. (2021)  Correlation of blood high mobility group box-1 protein with mortality of patients with sepsis: A meta-analysis. <i>Heart Lung<\/i>, 50, 885-892. https:\/\/doi.org\/10.1016\/j.hrtlng.2021.07.010","DOI":"10.1016\/j.hrtlng.2021.07.010"},{"key":"4","doi-asserted-by":"publisher","unstructured":"Chen, R., Kang, R.&amp;Tang, D. (2022)  The mechanism of HMGB1 secretion and release. <i>Exp. Mol. Med.<\/i>, 54, 91-102. https:\/\/doi.org\/10.1038\/s12276-022-00736-w","DOI":"10.1038\/s12276-022-00736-w"},{"key":"5","doi-asserted-by":"publisher","unstructured":"Choi, H., Yoo, H., Lee, J.Y., Park, J.&amp;Jeon, K. (2022)  Plasma Mitochondrial DNA and Necroptosis as Prognostic Indicators in Critically Ill Patients with Sepsis. <i>Biomedicines<\/i>, 10, 2386. https:\/\/doi.org\/10.3390\/biomedicines10102386","DOI":"10.3390\/biomedicines10102386"},{"key":"6","doi-asserted-by":"publisher","unstructured":"Deng, C., Zhao, L., Yang, Z., Shang, J.J., Wang, C.Y., Shen, M.Z., Jiang, S., Li, T., Di, W.C., Chen, Y., Li, H., Cheng, Y.D.&amp;Yang, Y. (2022)  Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury. <i>Acta Pharmacol. Sin.<\/i>, 43, 520-528. https:\/\/doi.org\/10.1038\/s41401-021-00676-7","DOI":"10.1038\/s41401-021-00676-7"},{"key":"7","doi-asserted-by":"publisher","unstructured":"DeWulf, B., Minsart, L., Verdonk, F., Kruys, V., Piagnerelli, M., Maze, M.&amp;Saxena, S. (2023)  High Mobility Group Box 1 (HMGB1): Potential Target in Sepsis-Associated Encephalopathy. <i>Cells<\/i>, 12, 1088. https:\/\/doi.org\/10.3390\/cells12071088","DOI":"10.3390\/cells12071088"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Eskici, Z.M., Acikgoz, S., Piskin, N., Mungan, G., Can, M., Guven, B.&amp;Kokturk, F. (2012)  High mobility group B1 levels in sepsis and Disseminated Intravascular Coagulation. <i>Acta Biochim. Pol<\/i>., 59, 561-566.","DOI":"10.18388\/abp.2012_2092"},{"key":"9","doi-asserted-by":"publisher","unstructured":"Fleischmann-Struzek, C.&amp;Rudd, K. (2023)  Challenges of assessing the burden of sepsis. <i>Med. Klin. Intensivmed Notfmed<\/i>, 118, 68-74. https:\/\/doi.org\/10.1007\/s00063-023-01088-7","DOI":"10.1007\/s00063-023-01088-7"},{"key":"10","doi-asserted-by":"publisher","unstructured":"Ga\u00efni, S., Pedersen, S.S., Koldkaer, O.G., Pedersen, C., Moestrup, S.K.&amp;Moller, H.J. (2008)  New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis. <i>Clin. Exp. Immunol.<\/i>, 151, 423-431. https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03586.x","DOI":"10.1111\/j.1365-2249.2007.03586.x"},{"key":"11","doi-asserted-by":"publisher","unstructured":"G\u00e1mez-D\u00edaz, L.Y., Enriquez, L.E., Matute, J.D., Velasquez, S., Gomez, I.D., Toro, F., Ospina, S., Bedoya, V., Arango, C.M., Valencia, M.L., De La Rosa, G., Gomez, C.I., Garcia, A., Patino, P.J.&amp;Jaimes, F.A. (2011)  Diagnostic accuracy of HMGB-1, sTREM-1, and CD64 as markers of sepsis in patients recently admitted to the emergency department. <i>Acad. Emerg. Med.<\/i>, 18, 807-815. https:\/\/doi.org\/10.1111\/j.1553-2712.2011.01113.x","DOI":"10.1111\/j.1553-2712.2011.01113.x"},{"key":"12","doi-asserted-by":"publisher","unstructured":"Gibot, S., Massin, F., Cravoisy, A., Barraud, D., Nace, L., Levy, B.&amp;Bollaert, P.E. (2007)  High-mobility group box 1 protein plasma concentrations during septic shock. <i>Intensive Care Med.<\/i>, 33, 1347-1353. https:\/\/doi.org\/10.1007\/s00134-007-0691-2","DOI":"10.1007\/s00134-007-0691-2"},{"key":"13","doi-asserted-by":"publisher","unstructured":"Hou, H.F., Liu, Y., Zhang, X., Han, Z.&amp;Chen, T. (2022)  The value of postoperative HLA-DR expression and high mobility group box 1 level in predictive diagnosis of sepsis in percutaneous nephrolithotomy surgery. <i>Ren. Fail.<\/i>, 44, 1338-1344. https:\/\/doi.org\/10.1080\/0886022X.2022.2107541","DOI":"10.1080\/0886022X.2022.2107541"},{"key":"14","doi-asserted-by":"publisher","unstructured":"Jacobi, J.(2022)  The pathophysiology of sepsis-2021 update: Part 1, immunology and coagulopathy leading to endothelial injury. <i>Am. J. Health Syst. Pharm.<\/i>, 79, 329-337. https:\/\/doi.org\/10.1093\/ajhp\/zxab380","DOI":"10.1093\/ajhp\/zxab380"},{"key":"15","doi-asserted-by":"publisher","unstructured":"Karlsson, S., Pettila, V., Tenhunen, J., Laru-Sompa, R., Hynninen, M.&amp;Ruokonen, E. (2008)  HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis. <i>Intensive Care Med.<\/i>, 34, 1046-1053. https:\/\/doi.org\/10.1007\/s00134-008-1032-9","DOI":"10.1007\/s00134-008-1032-9"},{"key":"16","doi-asserted-by":"publisher","unstructured":"Kocsis, A.K., Szabolcs, A., Hofner, P., Takacs, T., Farkas, G., Boda, K.&amp;Mandi, Y. (2009)  Plasma concentrations of high-mobility group box protein 1, soluble receptor for advanced glycation end-products and circulating DNA in patients with acute pancreatitis. <i>Pancreatology<\/i>, 9, 383-391. https:\/\/doi.org\/10.1159\/000181172","DOI":"10.1159\/000181172"},{"key":"17","doi-asserted-by":"publisher","unstructured":"Kumagai, T., Takeyama, N., Yabuki, T., Harada, M., Miki, Y., Kanou, H., Inoue, S., Nakagawa, T.&amp;Noguchi, H. (2010)  Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock. <i>Shock<\/i>, 34, 461-466. https:\/\/doi.org\/10.1097\/SHK.0b013e3181e14ca0","DOI":"10.1097\/SHK.0b013e3181e14ca0"},{"key":"18","doi-asserted-by":"publisher","unstructured":"Lee, K., Chang, Y., Song, K., Park, Y.Y., Huh, J.W., Hong, S.B., Lim, C.M.&amp;Koh, Y. (2016)  Associations between Single Nucleotide Polymorphisms of High Mobility Group Box 1 Protein and Clinical Outcomes in Korean Sepsis Patients. <i>Yonsei Med. J.<\/i>, 57, 111-117. https:\/\/doi.org\/10.3349\/ymj.2016.57.1.111","DOI":"10.3349\/ymj.2016.57.1.111"},{"key":"19","doi-asserted-by":"publisher","unstructured":"Lee, K.H., Cavanaugh, L., Leung, H., Yan, F., Ahmadi, Z., Chong, B.H.&amp;Passam, F. (2018)  Quantification of NETs-associated markers by flow cytometry and serum assays in patients with thrombosis and sepsis. <i>Int. J. Lab. Hematol.<\/i>, 40, 392-399. https:\/\/doi.org\/10.1111\/ijlh.12800","DOI":"10.1111\/ijlh.12800"},{"key":"20","doi-asserted-by":"publisher","unstructured":"Leligdowicz, A.&amp;Matthay, M.A. (2019)  Heterogeneity in sepsis: new biological evidence with clinical applications. <i>Crit. Care.<\/i>, 23, 80. https:\/\/doi.org\/10.1186\/s13054-019-2372-2","DOI":"10.1186\/s13054-019-2372-2"},{"key":"21","doi-asserted-by":"publisher","unstructured":"Li, L.&amp;Lu, Y.Q. (2020)  The Regulatory Role of High-Mobility Group Protein 1 in Sepsis-Related Immunity. <i>Front. Immunol.<\/i>, 11, 601815. https:\/\/doi.org\/10.3389\/fimmu.2020.601815","DOI":"10.3389\/fimmu.2020.601815"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Liu, D., Huang, S.Y., Sun, J.H., Zhang, H.C., Cai, Q.L., Gao, C., Li, L., Cao, J., Xu, F., Zhou, Y., Guan, C.X., Jin, S.W., Deng, J., Fang, X.M., Jiang, J.X., et al. (2022a)  Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. <i>Mil. Med. Res.<\/i>, 9, 56. https:\/\/doi.org\/10.1186\/s40779-022-00422-y","DOI":"10.1186\/s40779-022-00422-y"},{"key":"23","doi-asserted-by":"publisher","unstructured":"Liu, J., Song, K., Lin, B., Chen, Z., Zuo, Z., Fang, Y., He, Q., Yao, X., Liu, Z., Huang, Q.&amp;Guo, X. (2024)  HMGB1 promotes neutrophil PD-L1 expression through TLR2 and mediates T cell apoptosis leading to immunosuppression in sepsis. <i>Int. Immunopharmacol.<\/i>, 133, 112130. https:\/\/doi.org\/10.1016\/j.intimp.2024.112130","DOI":"10.1016\/j.intimp.2024.112130"},{"key":"24","doi-asserted-by":"publisher","unstructured":"Liu, Y.C., Yao, Y., Yu, M.M., Gao, Y.L., Qi, A.L., Jiang, T.Y., Chen, Z.S., Shou, S.T.&amp;Chai, Y.F. (2022b)  Frequency and mortality of sepsis and septic shock in China: a systematic review and meta-analysis. <i>BMC Infect. Dis.<\/i>, 22, 564. https:\/\/doi.org\/10.1186\/s12879-022-07543-8","DOI":"10.1186\/s12879-022-07543-8"},{"key":"25","doi-asserted-by":"publisher","unstructured":"Luo, D., Wan, X., Liu, J.&amp;Tong, T. (2018)  Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. <i>Stat. Methods. Med. Res.<\/i>, 27, 1785-1805. https:\/\/doi.org\/10.1177\/0962280216669183","DOI":"10.1177\/0962280216669183"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Ma, K., Zhang, Y., Hao, J., Zhao, J., Qi, Y.&amp;Liu, C. (2023)  Correlation analysis of systemic immune inflammatory index, Serum IL-35 and HMGB-1 with the severity and prognosis of sepsis. <i>Pak. J. Med. Sci.<\/i>, 39, 497-501. https:\/\/doi.org\/10.12669\/pjms.39.2.6651","DOI":"10.12669\/pjms.39.2.6651"},{"key":"27","doi-asserted-by":"publisher","unstructured":"Nakamura, T., Sato, E., Fujiwara, N., Kawagoe, Y., Suzuki, T., Ueda, Y., Yamada, S., Shoji, H., Takeuchi, M., Ueda, S., Matsui, T., Adachi, H., Okuda, S.&amp;Yamagishi, S. (2009)  Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock. <i>Pharmacol. Res.<\/i>, 60, 515-518. https:\/\/doi.org\/10.1016\/j.phrs.2009.05.002","DOI":"10.1016\/j.phrs.2009.05.002"},{"key":"28","doi-asserted-by":"publisher","unstructured":"Narvaez-Rivera, R.M., Rendon, A., Salinas-Carmona, M.C.&amp;Rosas-Taraco, A.G. (2012)  Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis. <i>BMC Infect. Dis.<\/i>, 12, 15. https:\/\/doi.org\/10.1186\/1471-2334-12-15","DOI":"10.1186\/1471-2334-12-15"},{"key":"29","doi-asserted-by":"publisher","unstructured":"Nishibori, M., Wang, D., Ousaka, D.&amp;Wake, H. (2020)  High Mobility Group Box-1 and Blood-Brain Barrier Disruption. <i>Cells<\/i>, 9, 2650. https:\/\/doi.org\/10.3390\/cells9122650","DOI":"10.3390\/cells9122650"},{"key":"30","doi-asserted-by":"publisher","unstructured":"Nobre, V., Ataide, T.B., Brant, L.C., Oliveira, C.R., Rodrigues, L.V., Ribeiro, A.L., Lopes, F.B., Saraiva, I.E.&amp;Andrade, M.V. (2016)  Use of reactive hyperemia - peripheral arterial tonometry and circulating biological markers to predict outcomes in sepsis. <i>Rev. Bras. Ter. Intensiva<\/i>, 28, 387-396. https:\/\/doi.org\/10.5935\/0103-507X.20160072","DOI":"10.5935\/0103-507X.20160072"},{"key":"31","doi-asserted-by":"publisher","unstructured":"Pan, S., Lv, Z., Wang, R., Shu, H., Yuan, S., Yu, Y.&amp;Shang, Y. (2022)  Sepsis-Induced Brain Dysfunction: Pathogenesis, Diagnosis, and Treatment. <i>Oxid. Med. Cell Longev.<\/i>, 2022, 1328729. https:\/\/doi.org\/10.1155\/2022\/1328729","DOI":"10.1155\/2022\/1328729"},{"key":"32","doi-asserted-by":"publisher","unstructured":"Raveendran, A.V., Kumar, A.&amp;Gangadharan, S. (2019)  Biomarkers and newer laboratory investigations in the diagnosis of sepsis. <i>J. R. Coll. Physicians Edinb.<\/i>, 49, 207-216. https:\/\/doi.org\/10.4997\/JRCPE.2019.308","DOI":"10.4997\/jrcpe.2019.308"},{"key":"33","doi-asserted-by":"publisher","unstructured":"Ravetti, C.G., Moura, A.D., Vieira, E.L., Pedroso, E.R.&amp;Teixeira, A.L. (2015)  sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock. <i>J. Crit. Care<\/i>, 30, 440 e447-413. https:\/\/doi.org\/10.1016\/j.jcrc.2014.12.002","DOI":"10.1016\/j.jcrc.2014.12.002"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Rudd, K.E., Johnson, S.C., Agesa, K.M., Shackelford, K.A., Tsoi, D., Kievlan, D.R., Colombara, D.V., Ikuta, K.S., Kissoon, N., Finfer, S., Fleischmann-Struzek, C., Machado, F.R., Reinhart, K.K., Rowan, K., Seymour, C.W., et al. (2020)  Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. <i>Lancet<\/i>, 395, 200-211. https:\/\/doi.org\/10.1016\/S0140-6736(19)32989-7","DOI":"10.1016\/S0140-6736(19)32989-7"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Stang, A.(2010)  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. <i>Eur. J. Epidemiol.<\/i>, 25, 603-605. https:\/\/doi.org\/10.1007\/s10654-010-9491-z","DOI":"10.1007\/s10654-010-9491-z"},{"key":"36","doi-asserted-by":"publisher","unstructured":"Stevens, N.E., Chapman, M.J., Fraser, C.K., Kuchel, T.R., Hayball, J.D.&amp;Diener, K.R. (2017)  Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes. <i>Sci. Rep.<\/i>, 7, 5850. https:\/\/doi.org\/10.1038\/s41598-017-06205-z","DOI":"10.1038\/s41598-017-06205-z"},{"key":"37","doi-asserted-by":"publisher","unstructured":"Sun, Z., Song, Y., Li, J., Li, Y., Yu, Y.&amp;Wang, X. (2023)  Potential biomarker for diagnosis and therapy of sepsis: Lactylation. <i>Immun. Inflamm. Dis.<\/i>, 11, e1042. https:\/\/doi.org\/10.1002\/iid3.1042","DOI":"10.1002\/iid3.1042"},{"key":"38","doi-asserted-by":"publisher","unstructured":"Taverna, S., Tonacci, A., Ferraro, M., Cammarata, G., Cuttitta, G., Bucchieri, S., Pace, E.&amp;Gangemi, S. (2022)  High Mobility Group Box 1: Biological Functions and Relevance in Oxidative Stress Related Chronic Diseases. <i>Cells<\/i>, 11, 849. https:\/\/doi.org\/10.3390\/cells11050849","DOI":"10.3390\/cells11050849"},{"key":"39","doi-asserted-by":"publisher","unstructured":"Ueno, T., Ikeda, T., Ikeda, K., Taniuchi, H., Suda, S., Yeung, M.Y.&amp;Matsuno, N. (2011)  HMGB-1 as a useful prognostic biomarker in sepsis-induced organ failure in patients undergoing PMX-DHP. <i>J. Surg. Res.<\/i>, 171, 183-190. https:\/\/doi.org\/10.1016\/j.jss.2009.11.708","DOI":"10.1016\/j.jss.2009.11.708"},{"key":"40","doi-asserted-by":"publisher","unstructured":"van Zoelen, M.A., Laterre, P.F., van Veen, S.Q., van Till, J.W., Wittebole, X., Bresser, P., Tanck, M.W., Dugernier, T., Ishizaka, A., Boermeester, M.A.&amp;van der Poll, T. (2007)  Systemic and local high mobility group box 1 concentrations during severe infection. <i>Crit. Care Med.<\/i>, 35, 2799-2804. https:\/\/doi.org\/10.1097\/01.CCM.0000287588.69000.97","DOI":"10.1097\/01.CCM.0000287588.69000.97"},{"key":"41","doi-asserted-by":"publisher","unstructured":"Walborn, A., Rondina, M., Fareed, J.&amp;Hoppensteadt, D. (2020)  Development of an Algorithm to Predict Mortality in Patients With Sepsis and Coagulopathy. <i>Clin. Appl. Thromb. Hemost.<\/i>, 26, 1076029620902849. https:\/\/doi.org\/10.1177\/1076029620902849","DOI":"10.1177\/1076029620902849"},{"key":"42","doi-asserted-by":"publisher","unstructured":"Walborn, A., Rondina, M., Mosier, M., Fareed, J.&amp;Hoppensteadt, D. (2019)  Endothelial Dysfunction Is Associated with Mortality and Severity of Coagulopathy in Patients with Sepsis and Disseminated Intravascular Coagulation. <i>Clin. Appl. Thromb. Hemost.<\/i>, 25, 1076029619852163. https:\/\/doi.org\/10.1177\/1076029619852163","DOI":"10.1177\/1076029619852163"},{"key":"43","doi-asserted-by":"publisher","unstructured":"Wan, X., Wang, W., Liu, J.&amp;Tong, T. (2014)  Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. <i>BMC Med. Res. Methodol.<\/i>, 14, 135. https:\/\/doi.org\/10.1186\/1471-2288-14-135","DOI":"10.1186\/1471-2288-14-135"},{"key":"44","doi-asserted-by":"publisher","unstructured":"Wang, J., Wu, C., Wang, Y., Chen, C., Cheng, J., Rao, X.&amp;Sun, H. (2021)  The Role of HMGB1 in Invasive Candida albicans Infection. <i>Mycopathologia<\/i>, 186, 789-805. https:\/\/doi.org\/10.1007\/s11046-021-00595-5","DOI":"10.1007\/s11046-021-00595-5"},{"key":"45","doi-asserted-by":"publisher","unstructured":"Wang, X.W., Karki, A., Zhao, X.J., Xiang, X.Y.&amp;Lu, Z.Q. (2014)  High plasma levels of high mobility group box 1 is associated with the risk of sepsis in severe blunt chest trauma patients: a prospective cohort study. <i>J. Cardiothorac. Surg.<\/i>, 9, 133. https:\/\/doi.org\/10.1186\/s13019-014-0133-5","DOI":"10.1186\/s13019-014-0133-5"},{"key":"46","doi-asserted-by":"publisher","unstructured":"Wu, J., Ren, J., Liu, Q., Hu, Q., Wu, X., Wang, G., Hong, Z., Ren, H.&amp;Li, J. (2019)  Effects of Changes in the Levels of Damage-Associated Molecular Patterns Following Continuous Veno-Venous Hemofiltration Therapy on Outcomes in Acute Kidney Injury Patients With Sepsis. <i>Front. Immunol.<\/i>, 9, 3052. https:\/\/doi.org\/10.3389\/fimmu.2018.03052","DOI":"10.3389\/fimmu.2018.03052"},{"key":"47","doi-asserted-by":"publisher","unstructured":"Yagmur, E., Buendgens, L., Herbers, U., Beeretz, A., Weiskirchen, R., Koek, G.H., Trautwein, C., Tacke, F.&amp;Koch, A. (2018)  High mobility group box 1 as a biomarker in critically ill patients. <i>J. Clin. Lab. Anal.<\/i>, 32, e22584. https:\/\/doi.org\/10.1002\/jcla.22584","DOI":"10.1002\/jcla.22584"},{"key":"48","doi-asserted-by":"publisher","unstructured":"Yoo, H., Im, Y., Ko, R.E., Lee, J.Y., Park, J.&amp;Jeon, K. (2021)  Association of plasma level of high-mobility group box-1 with necroptosis and sepsis outcomes. <i>Sci. Rep.<\/i>, 11, 9512. https:\/\/doi.org\/10.1038\/s41598-021-88970-6","DOI":"10.1038\/s41598-021-88970-6"},{"key":"49","doi-asserted-by":"publisher","unstructured":"Zang, D., Li, W., Cheng, F., Zhang, X., Rao, T., Yu, W., Wei, J., Song, Y.&amp;Jiang, W. (2022)  Accuracy and sensitivity of high mobility group box 1 (HMGB1) in diagnosis of acute kidney injury caused by sepsis and relevance to prognosis. <i>Clin. Chim. Acta.<\/i>, 535, 61-67. https:\/\/doi.org\/10.1016\/j.cca.2022.07.015","DOI":"10.1016\/j.cca.2022.07.015"},{"key":"50","doi-asserted-by":"publisher","unstructured":"Zhu, C.S., Wang, W., Qiang, X., Chen, W., Lan, X., Li, J.&amp;Wang, H. (2021)  Endogenous Regulation and Pharmacological Modulation of Sepsis-Induced HMGB1 Release and Action: An Updated Review. <i>Cells<\/i>, 10, 2220. https:\/\/doi.org\/10.3390\/cells10092220","DOI":"10.3390\/cells10092220"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/269\/2\/269_2025.J085\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:22:47Z","timestamp":1781925767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/269\/2\/269_2025.J085\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2025.j085","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2025.J085"}}